Absci Corp 8-K

What Happened

• Absci Corporation announced its financial results for the fourth quarter ended December 31, 2025 via a press release furnished on Form 8-K on March 24, 2026. The press release is filed as Exhibit 99.1 to the 8-K.
• On the same date the company released a corporate presentation with internal pipeline program updates, which is filed as Exhibit 99.2 and posted in the “News & Events” section of Absci’s website. The filing is signed by Shelby Walker, Chief Legal Officer.

Key Details

• Date of filing/announcement: March 24, 2026.
• Reporting period: Fourth quarter ended December 31, 2025.
• Exhibits filed: Exhibit 99.1 (press release) and Exhibit 99.2 (corporate presentation with pipeline updates).
• Presentation content: includes internal pipeline program updates (available on company website).

Why It Matters

• The 8-K signals that Absci has released its quarterly results and related investor materials; investors should review the press release and presentation for revenue, expenses, cash position, and any management commentary that affect valuation.
• Pipeline updates in the presentation are material for a biotech-related investment thesis, as progress or timelines for internal programs can influence future revenue potential and partnership/licensing opportunities.
• Because the filing provides direct access to the company’s press release and slide deck (Exhibits 99.1 and 99.2), retail investors can read the source documents to get specific numbers and management guidance rather than relying on third-party summaries.